
Lung cancer is the leading cause of cancer death worldwide, accounting for more deaths than breast, prostate and colon cancer zzso While treatment decisions are determined primarily by stage, zzso non small cell lung cancer zzso has traditionally been treated as a single zzso However, recent findings have led to the recognition of zzso and molecular zzso as important zzso in treatment zzso zzso the genetic differences that define these molecular and zzso zzso has the potential to impact treatment and as such is currently the focus of much zzso zzso and zzso sequencing efforts have provided unparalleled insight into the zzso of lung cancer zzso specifically zzso zzso and zzso cell zzso zzso revealing zzso specific zzso zzso and molecular zzso as well as differences in cell signaling zzso In this review, we discuss the zzso zzso zzso characteristic of zzso and zzso (including molecular zzso their therapeutic implications and emerging clinical practices aimed at tailoring treatments based on a zzso molecular zzso with the hope of improving patient response and zzso 

